A Phase I-II Trial of Antigen-Pulsed Autologous Dendritic Cells for Induction of Anti-Tumor Immunity in Patients Completing Lymphadenectomy for Metastatic Melanoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dendritic cell vaccines; Dendritic cells; MDX 1379; Peptide vaccines; Vaccinia melanoma cell lysate vaccine
- Indications Malignant melanoma
- Focus Therapeutic Use
- 05 Apr 2013 New trial record
- 25 Mar 2013 Biomarkers information updated